These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 39192278)

  • 21. Burden of Disease and Productivity Loss in the European Economic Area in Patients Affected by Fibrosing Interstitial Lung Disease.
    Løkke A; Castello L; Pinheiro Martins P; Soulard S; Hilberg O
    Adv Ther; 2023 Dec; 40(12):5502-5518. PubMed ID: 37837527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Claims-based Prevalence of Disease Progression among Patients with Fibrosing Interstitial Lung Disease Other than Idiopathic Pulmonary Fibrosis in the United States.
    Singer D; Bengtson LGS; Conoscenti CS; Laouri M; Shetty SS; Anderson AJ; Brown KK
    Ann Am Thorac Soc; 2022 Jul; 19(7):1112-1121. PubMed ID: 35015982
    [No Abstract]   [Full Text] [Related]  

  • 23. [Epidemiology of fibrosing interstitial lung diseases in the department of Haute Garonne].
    Villeneuve T; Prévot G; Lintz F; Mourin G; Ferry G; Bousquet E; Perelroizen H; Boghanim T; Faviez G; Noël-Savina E; Collot S; Le Borgne A; Didier A
    Rev Mal Respir; 2021 Dec; 38(10):972-979. PubMed ID: 34629221
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Baseline characteristics and comorbidities in the CAnadian REgistry for Pulmonary Fibrosis.
    Fisher JH; Kolb M; Algamdi M; Morisset J; Johannson KA; Shapera S; Wilcox P; To T; Sadatsafavi M; Manganas H; Khalil N; Hambly N; Halayko AJ; Gershon AS; Fell CD; Cox G; Ryerson CJ
    BMC Pulm Med; 2019 Nov; 19(1):223. PubMed ID: 31771541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cough-Specific Quality of Life Predicts Disease Progression Among Patients With Interstitial Lung Disease: Data From the Pulmonary Fibrosis Foundation Patient Registry.
    Lee J; White E; Freiheit E; Scholand MB; Strek ME; Podolanczuk AJ; Patel NM;
    Chest; 2022 Sep; 162(3):603-613. PubMed ID: 35337809
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gremlin-1 for the Differential Diagnosis of Idiopathic Pulmonary Fibrosis Versus Other Interstitial Lung Diseases: A Clinical and Pathophysiological Analysis.
    Aoshima Y; Enomoto Y; Muto S; Meguro S; Kawasaki H; Kosugi I; Fujisawa T; Enomoto N; Inui N; Nakamura Y; Suda T; Iwashita T
    Lung; 2021 Jun; 199(3):289-298. PubMed ID: 33770226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A cohort study of interstitial lung diseases in central Denmark.
    Hyldgaard C; Hilberg O; Muller A; Bendstrup E
    Respir Med; 2014 May; 108(5):793-9. PubMed ID: 24636811
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cough, an unresolved problem in interstitial lung diseases.
    van Manen MJG; Wijsenbeek MS
    Curr Opin Support Palliat Care; 2019 Sep; 13(3):143-151. PubMed ID: 31365459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence and Incidence of Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype in the United States Estimated in a Large Claims Database Analysis.
    Olson AL; Patnaik P; Hartmann N; Bohn RL; Garry EM; Wallace L
    Adv Ther; 2021 Jul; 38(7):4100-4114. PubMed ID: 34156606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute exacerbations of fibrotic interstitial lung diseases.
    Suzuki A; Kondoh Y; Brown KK; Johkoh T; Kataoka K; Fukuoka J; Kimura T; Matsuda T; Yokoyama T; Fukihara J; Ando M; Tanaka T; Hashimoto N; Sakamoto K; Hasegawa Y
    Respirology; 2020 May; 25(5):525-534. PubMed ID: 31426125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and economic burden of acute exacerbations of idiopathic pulmonary fibrosis: a prospective observational study in Spain (OASIS study).
    Gómez AV; Rodríguez-Nieto MJ; Cano-Jiménez E; Ortiz AR; Morros M; Ramon A; Armengol S
    BMC Pulm Med; 2024 Jul; 24(1):370. PubMed ID: 39080648
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of characteristics of connective tissue disease-associated interstitial lung diseases, undifferentiated connective tissue disease-associated interstitial lung diseases, and idiopathic pulmonary fibrosis in Chinese Han population: a retrospective study.
    Pan L; Liu Y; Sun R; Fan M; Shi G
    Clin Dev Immunol; 2013; 2013():121578. PubMed ID: 24171031
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unravelling the health and economic burden of interstitial lung diseases in adults in Australia.
    Cox IA; de Graaff B; Zheng Q; Corte TJ; Haydn Walters E; Palmer AJ
    Aust J Gen Pract; 2024 May; 53(5):333-336. PubMed ID: 38697068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Responsiveness and meaningful change thresholds of the Living with Pulmonary Fibrosis (L-PF) questionnaire Dyspnoea and Cough scores in patients with progressive fibrosing interstitial lung diseases.
    Swigris JJ; Bushnell DM; Rohr K; Mueller H; Baldwin M; Inoue Y
    BMJ Open Respir Res; 2022 Mar; 9(1):. PubMed ID: 35241434
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Using Data on Survival with Idiopathic Pulmonary Fibrosis to Estimate Survival with Other Types of Progressive Fibrosis Interstitial Lung Disease: A Bayesian Framework.
    Langford B; Diamantopoulos A; Maher TM; Inoue Y; Rohr KB; Baldwin M
    Adv Ther; 2022 Feb; 39(2):1045-1054. PubMed ID: 34957531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Economic burden of incident interstitial lung disease (ILD) and the impact of comorbidity on costs of care.
    Frank AL; Kreuter M; Schwarzkopf L
    Respir Med; 2019 Jun; 152():25-31. PubMed ID: 31128606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The epidemiology of idiopathic pulmonary fibrosis and interstitial lung diseases at risk of a progressive-fibrosing phenotype.
    Olson AL; Gifford AH; Inase N; Fernández Pérez ER; Suda T
    Eur Respir Rev; 2018 Dec; 27(150):. PubMed ID: 30578336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in patient-reported outcomes in patients with non-idiopathic pulmonary fibrosis fibrotic interstitial lung disease and progressive pulmonary fibrosis.
    Takei R; Matsuda T; Fukihara J; Sasano H; Yamano Y; Yokoyama T; Kataoka K; Kimura T; Suzuki A; Furukawa T; Fukuoka J; Johkoh T; Kondoh Y
    Front Med (Lausanne); 2023; 10():1067149. PubMed ID: 37457568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Causes of acute respiratory hospitalizations predict survival in fibrosing interstitial lung diseases.
    Salonen J; Vähänikkilä H; Purokivi M; Kaarteenaho R
    PLoS One; 2020; 15(11):e0242860. PubMed ID: 33253258
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessing health-related quality of life in patients with interstitial lung diseases.
    Stoltefuß S; Leuschner G; Milger K; Kauke T; Götschke J; Veit T; Lenoir A; Kneidinger N; Behr J
    BMC Pulm Med; 2024 Sep; 24(1):452. PubMed ID: 39272068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.